Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death

Biochemical and Biophysical Research Communications

Volumn 362, Issue 4, 2007, Pages 1063-1068

  Kaga, Chiaki ^a   Okochi, Mina ^a   Nakanishi, Mari ^a   Hayashi, Hiroki ^a   Kato, Ryuji ^a   Honda, Hiroyuki ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Peptide array; Peptide drug; SPOT synthesis; TRAIL

Indexed keywords

CASPASE; CASPASE 3; CYSTEINE; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DNA FRAGMENT; LYSINE; PEPTIDE; PHOSPHATIDYLSERINE; SERINE; TRYPTOPHAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; BINDING COMPETITION; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MICROARRAY; SCREENING; TUMOR CELL;

AMINO ACID SEQUENCE; APOPTOSIS; CASPASES; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 34548575224     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.08.110     Document Type: Article

References (20)

1. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A., and Goodwin R.G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3 (1995) 673-682
2. Jones E.Y., Stuart D.I., and Walker N.P. Structure of tumour necrosis factor. Nature 338 (1989) 225-228
3. Ashkenazi A., Pai R.C., Fong S., Leung S., Lawrence D.A., Marsters S.A., Blackie C., Chang L., McMurtrey A.E., Hebert A., DeForge L., Koumenis I.L., Lewis D., Harris L., Bussiere J., Koeppen H., Shahrokh Z., and Schwall R.H. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104 (1999) 155-162
4. Ichikawa K., Liu W., Zhao L., Wang Z., Liu D., Ohtsuka T., Zhang H., Mountz J.D., Koopman W.J., Kimberly R.P., and Zhou T. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat. Med. 7 (2001) 954-960
5. van der Sloot A.M., Mullally M.M., Fernandez-Ballester G., Serrano L., and Quax W.J. Stabilization of TRAIL, an all-beta-sheet multimeric protein, using computational redesign. Protein Eng. Des. Sel. 17 (2004) 673-680
6. Guo Y., Chen C., Zheng Y., Zhang J., Tao X., Liu S., Zheng D., and Liu Y. A novel anti-human DR5 monoclonal antibody with tumoricidal activity induces caspase-dependent and caspase-independent cell death. J. Biol. Chem. 280 (2005) 41940-41952
7. van der Sloot A.M., Tur V., Szegezdi E., Mullally M.M., Cool R.H., Samali A., Serrano L., and Quax W.J. Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor. Proc. Natl. Acad. Sci. USA 103 (2006) 8634-8639
8. Li B., Russell S.J., Compaan D.M., Totpal K., Marsters S.A., Ashkenazi A., Cochran A.G., Hymowitz S.G., and Sidhu S.S. Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists. J. Mol. Biol. 361 (2006) 522-536
9. Kato R., Kunimatsu M., Fujimoto S., Kobayashi T., and Honda H. Angiotensin II inhibitory peptide found in the receptor sequence using peptide array. Biochem. Biophys. Res. Commun. 315 (2004) 22-29
10. Yoshimori A., Takasawa R., Hayakawa A., Mizuno M., Yoshida J., and Tanuma S. Structure-based design of an agonistic peptide targeting Fas. Apoptosis 10 (2005) 323-329
11. Yagi Y., Terada K., Noma T., Ikebukuro K., and Sode K. In silico panning for a non-competitive peptide inhibitor. BMC Bioinformatics 8 (2007) 11
12. Hilpert K., Volkmer-Engert R., Walter T., and Hancock R.E. High-throughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol. 23 (2005) 1008-1012
13. Frank R. The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J. Immunol. Methods 267 (2002) 13-26
14. Kramer A., and Schneider-Mergener J. Synthesis and screening of peptide libraries on continuous cellulose membrane supports. Methods Mol. Biol. 87 (1998) 25-39
15. Reineke U., Volkmer-Engert R., and Schneider-Mergener J. Applications of peptide arrays prepared by the SPOT-technology. Curr. Opin. Biotechnol. 12 (2001) 59-64
16. Kato R., Okuno Y., Kaga C., Kunimatsu M., Kobayashi T., and Honda H. Pentamer peptide from Fas antigen ligand inhibits tumor-growth with solid-bound form found by peptide array. J. Pept. Res. 66 Suppl 1 (2005) 146-153
17. Okochi M., Nakanishi M., Kato R., Kobayashi T., and Honda H. High-throughput screening of cell death inducible short peptides from TNF-related apoptosis-inducing ligand sequence. FEBS Lett. 580 (2006) 885-889
18. Kato R., Kaga C., Kunimatsu M., Kobayashi T., and Honda H. Peptide array-based interaction assay of solid-bound peptides and anchorage-dependant cells and its effectiveness in cell-adhesive peptide design. J. Biosci. Bioeng. 101 (2006) 485-495
19. Ellerby H.M., Arap W., Ellerby L.M., Kain R., Andrusiak R., Rio G.D., Krajewski S., Lombardo C.R., Rao R., Ruoslahti E., Bredesen D.E., and Pasqualini R. Anti-cancer activity of targeted pro-apoptotic peptides. Nat. Med. 5 (1999) 1032-1038
20. 2-terminal pentapeptide of endothelial interleukin 8 is responsible for the induction of apoptosis in leukemic cells and has an antitumor effect in vivo. Cancer Res. 59 (1999) 5651-5655